Moreover, downregulation of p62 reduces IL-8 levels and increases CRC cell sensitivity to 5-fluorouracil (5-FU) and oxaliplatin (OxaPt), indicating its prognostic value as a predictor of treatment response [176]. This evidence concerns the gene SQSTM1 and colorectal carcinoma.